Concourse Financial Group Securities’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3982 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5203 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5189 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5222 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5226 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5169 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5092 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5002 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4841 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4823 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4634 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 4659 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4585 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4632 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4530 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4396 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4286 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4187 |
|